On 3 January 2023, Arkema finalized the divestment of Febex, a company specialized in phosphorus-based chemistry, to Belgian group Prayon.
Febex is a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry.
Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of around €30 million in 2021, employs 59 people, and operates 1 site in Switzerland.
Arkema thus continues its dynamic business portfolio management.
